- Home
- TEVA
as 11-20-2024 4:00pm EST
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
| Founded: | 1901 | Country: | Israel |
| Employees: | N/A | City: | TEL AVIV |
| Market Cap: | 19.2B | IPO Year: | N/A |
| Target Price: | $19.63 | AVG Volume (30 days): | 7.4M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 8 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.86 | EPS Growth: | N/A |
| 52 Week Low/High: | $9.35 - $19.31 | Next Earning Date: | 11-06-2024 |
| Revenue: | $16,772,000,000 | Revenue Growth: | 9.81% |
| Revenue Growth (this year): | 4.7% | Revenue Growth (next year): | 4.47% |
Latest Teva Pharmaceutical Industries Limited News
TEVA Breaking Stock News: Dive into TEVA Ticker-Specific Updates for Smart Investing
Insider Monkey
5 hours ago
Teva Pharmaceutical (TEVA): The Global Leader in Affordable Medicine Under $25
Argus Research
3 days ago
Weekly Stock List
Insider Monkey
6 days ago
Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory
Argus Research
7 days ago
Analyst Report: Teva Phar Inds Lt
Argus Research
7 days ago
Market Update: CP, TEVA, MET, IGT
GlobeNewswire
13 days ago
Teva to Present at the Jefferies London Healthcare Conference
Zacks
13 days ago
Are Investors Undervaluing Teva Pharmaceutical Industries (TEVA) Right Now?
Zacks
14 days ago
Amicus' Q3 Earnings & Revenues Beat Estimates, '24 View Updated
Compare TEVA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TEVA Teva Pharmaceutical Industries Limited - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.